[Clinical use of thrombocyte concentrate in the treatment of jaw alveolitis].
The authors present new method of the treatment of the chronic alveolitis. It includes the use of FRP-plasma, which improves healing of the socket thanks to the presence of thrombocytes that contains PDGF-aa, PDGF-bb, PDGF-ab (PDGF--platelete derived growth factor), TGF-beta1, TGF-beta2 (TGF-transforming growth factor). These factors initiate bone regeneration, VEGF (vessel endothelium growth factor) and EGF (epithelium growth factor), IGF (insulin like growth factor).
Sehal
Iu V
IuV
Chumachenko
O V
OV
Kul'bashna
Ia A
IaA
D016301:Alveolar Bone Loss / Q000517:prevention & control*; D001792:Blood Platelets / Q000378:metabolism; D002908:Chronic Disease; D016557:Guided Tissue Regeneration, Periodontal / Q000379:methods*; D006801:Humans; D007571:Jaw Diseases / Q000628:therapy*; D017713:Platelet Transfusion; D010982:Platelet-Derived Growth Factor / Q000378:metabolism; D014081:Tooth Extraction; D016212:Transforming Growth Factor beta / Q000378:metabolism; D016896:Treatment Outcome
D010982:Platelet-Derived Growth Factor; D016212:Transforming Growth Factor beta